Botulinum Toxin Type A News
Botulinum Toxin Type A currently has 1 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Botulinum Toxin Type A with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines), when the severity of the above facial lines has an important...
- Evidence level: L5
- Predicted indications (20):
- primary hereditary glaucoma (89.4%)
- parkinsonian disorder (88.8%)
- open-angle glaucoma (88.8%)
- insomnia (disease) (87.5%)
- glaucoma 1, open angle (79.0%)
- restless legs syndrome (77.9%)
- Parkinson disease (77.7%)
- paralysis agitans, juvenile, of Hunt (77.3%)
- bronchitis (75.8%)
- autosomal recessive Parkinson disease (73.3%)
- lethal infantile mitochondrial myopathy (73.1%)
- enterocolitis (disease) (73.0%)
- glaucoma (72.8%)
- irritable bowel syndrome (72.7%)
- open angle glaucoma (72.0%)
- progressive supranuclear palsy-corticobasal syndrome (71.5%)
- anxiety (70.3%)
- headache disorder (70.2%)
- sleep disorder, initiating and maintaining sleep (69.2%)
- trigeminal autonomic cephalalgia (69.1%)
Related News (1)
Vous êtes fatigué en ce début d’automne ? C’est normal mais vous pouvez y remédier - Le HuffPost
2026-10-10 EPOC
Source: Le HuffPost
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.